1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA CA2 CTRPv2 pan-cancer AAC 0.12 0.0005
mRNA HIKESHI CTRPv2 pan-cancer AAC -0.12 0.0005
mRNA VASN CTRPv2 pan-cancer AAC -0.13 0.0005
mRNA AJUBA CTRPv2 pan-cancer AAC -0.14 0.0005
mRNA SMARCC2 CTRPv2 pan-cancer AAC -0.13 0.0005
mRNA NUDT13 CTRPv2 pan-cancer AAC 0.12 0.0006
mRNA STX2 CTRPv2 pan-cancer AAC -0.14 0.0006
mRNA S100A11 CTRPv2 pan-cancer AAC 0.14 0.0006
mRNA UBE2E2 CTRPv2 pan-cancer AAC -0.12 0.0006
mRNA HACD1 CTRPv2 pan-cancer AAC -0.13 0.0006
Download CSV